NCT06405321 2026-01-14
Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma
Guangxi Medical University
Recruiting
Clinical Trials
23 trialsNCT07054086 2025-07-08
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Recruiting
NCT06978322 2025-05-18
Comparative Study Between Immediate Surgery Versus Neoadjuvant Chemotherapy for Management of Resectable Pancreatic Cancer
Minia University
Recruiting
NCT06889402 2025-03-21
Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06868693 2025-03-11
PEACE
Azienda Unita Sanitaria Locale di Piacenza
Not yet recruiting
NCT06792149 2025-01-24
Prediction of Drug Response in Gastric Cancer Based on 3D Bioprinting
Peking Union Medical College Hospital
Recruiting
NCT06630481 2024-10-08
CAP with NAT
Seoul National University Hospital
Completed
NCT06556355 2024-08-16
Anastomotic Leaks in Esophageal Squamous Cell Carcinoma Patients After Trimodal Therapy
Sun Yat-sen University
Completed
NCT06369480 2024-04-17
Prognostic Factors for Survival in Patients With Cholangiocarcinoma
Rigshospitalet, Denmark
Recruiting
NCT06261138 2024-02-15
Survival Analysis: TACE vs. Combination Therapy in HCC
Zhejiang University
Completed
NCT06129812 2023-11-13
An Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
Seoul National University Hospital
Completed
NCT06035250 2023-09-28
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Chinese Academy of Sciences
Recruiting
NCT05592873 2022-10-25
I-ONARC
Niguarda Hospital
Completed
NCT05496270 2022-08-11
Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer
Sun Yat-sen University
Completed
NCT05495308 2022-08-10
"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".
Hospital San Carlos, Madrid
Completed
NCT04755907 2022-07-19
3D Bioprinted Models for Predicting Chemotherapy Response in Colorectal Cancer With/Without Liver Metastases
Peking Union Medical College Hospital
Unknown
NCT03699410 2021-10-13
LiBReCa
Ente Ospedaliero Cantonale, Bellinzona
Terminated
NCT04513457 2021-03-29
Chemotherapy for Resectable Colorectal Liver Metastases
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Completed
NCT04027543 2020-05-29
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma（NewEC Study）
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT04408859 2020-05-29
Quality of Life in Advanced Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Peking University Cancer Hospital & Institute
Unknown
NCT03899870 2019-04-02
Factors Predicting Recurrence in Rectal Cancer After Surgery
Université de Sousse
Completed
NCT03469375 2018-03-27
Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Completed
NCT03151759 2017-05-12
MMP-7
Region Skane
Completed